BCSS
Bain Capital GSS Investment Cor
There isn't enough reported data to score BCSS yet.
BCSS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
BCSS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCSS.
BCSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 49x | $10.24 | 0% |
| Current | 49x | $10.24 | โ |
| Fair | 73x | $15.23 | +49% |
| Expensive | 73x | $15.32 | +50% |
Historical ranges are pointers, not guarantees.
BCSS's PE is 49x, but its earnings don't support one, so it isn't a reliable read right now.
BCSS Forward outlook
There aren't enough analyst estimates for BCSS to show an outlook.
BCSS Earnings Per Share
BCSS Quarterly Revenue
BCSS Free Cash Flow
BCSS Net Leverage
BCSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 21.5 | Neutral |
BCSS's weekly RSI is 51 (neutral) and its Stochastic is 22 (neutral).
BCSS PE vs Financial Services Sector
| Metric | BCSS | Sector median | Relative |
|---|---|---|---|
| PE | 49x | 13x | 275% above |
BCSS is trading at 49x earnings, a 275% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BCSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 0% above |
| 20 week MA | $10.3 | 0.1% below |
| 50 week MA | $10.2 | 0.5% above |
BCSS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 0.5% above its 50-week average.
BCSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $10.1 | $10.1 | 0% |
| 2026 YTD | $10.1 | $10.2 | +1.6% |
BCSS has finished every year since 2025 lower, and it's up 1.6% so far in 2026.